Desq Long
Sign in

Company

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV · CIK 0001801170

SEC FORM 4
$8,759.76

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Sale of 1,921 shares at $4.56 per share.

Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001839066-26-000047 · filed 2026-09-18 · View filing →

SEC FORM 4
$14,708.80

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Sale of 3,170 shares at $4.64 per share.

Reporting Person OLDAKOWSKI JOSEPH FRANK · Officer Title VP OF FINANCE AND CONTROLLER · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001801170-26-000223 · filed 2026-09-17 · View filing →

SEC FORM 4
$1,416,000.00

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Sale of 300,000 shares at $4.72 per share.

Reporting Person Wai Conrad · Officer Title CEO, Counterpart Health · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001971702-26-000017 · filed 2026-09-16 · View filing →

SEC FORM 4
$44,324.94

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Sale of 9,273 shares at $4.78 per share.

Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001839066-26-000045 · filed 2026-09-15 · View filing →

SEC FORM 4
$32,723.88

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Sale of 6,846 shares at $4.78 per share.

Reporting Person Soares Karen · Officer Title Chief Legal Officer · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001999086-26-000031 · filed 2026-09-15 · View filing →

SEC FORM 4
$103,200.00

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Sale of 20,000 shares at $5.16 per share.

Reporting Person OLDAKOWSKI JOSEPH FRANK · Officer Title VP OF FINANCE AND CONTROLLER · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001801170-26-000218 · filed 2026-09-14 · View filing →

SEC FORM 4
$78,032.25

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Sale of 17,775 shares at $4.39 per share.

Reporting Person THORNTON JOSEPH CLAY · Officer Title Interim CFO · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001801170-26-000207 · filed 2026-08-17 · View filing →

SEC FORM 4
$0.00

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Acquisition (code A) of 54,347 shares at $0 per share.

Reporting Person THORNTON JOSEPH CLAY · Officer Title Interim CFO · Transaction Code A

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001801170-26-000202 · filed 2026-08-13 · View filing →

SEC FORM 4
$0.00

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Acquisition (code A) of 108,695 shares at $0 per share.

Reporting Person Soares Karen · Officer Title Chief Legal Officer · Transaction Code A

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001999086-26-000023 · filed 2026-08-13 · View filing →